Skip to main content
. 2019 Mar 30;9(3):e022478. doi: 10.1136/bmjopen-2018-022478

Table 3.

Risk factors associated with thromboembolic events (PREvention oF thromboembolic events - European Registry in Atrial Fibrillation derivation cohort)

Variable OR 95% CI P value Score
Abnormal liver function* 2.86 1.24 to 6.63 0.0141 2
Labile INR† 2.83 1.83 to 4.38 <0.0001 2
Drugs‡ 2.41 1.58 to 3.69 <0.0001 1
Prior stroke/TIA/thromboembolic event 2.79 1.81 to 4.28 <0.0001 2
Heart failure 2.20 1.45 to 3.33 0.0002 1
Age ≥75 years 1.53 1.00 to 2.33 0.0482 1

*Presence of cirrhosis, elevated liver transaminases or alkaline phosphatase >3 times above the upper limit of normal (ULN), or bilirubin >2 times above the ULN.

†<60% time in therapeutic range.

‡Antiplatelet agents or non-steroidal anti-inflammatory drugs.

INR, international normalised ratio; TIA, transient ischaemic attack.